Physician profile
Mark J Perna
NPI 1871790113
$19,553.49
in general payments reported to CMS, 2019-2025
23 companies · $2,503 in 2025
The $2,503 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $16.63 · 2022: $302 · 2023: $183 · 2024: $16K · 2025: $2,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $5,058 · Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,092.30 |
| Travel and Lodging | $5,058.20 |
| Food and Beverage | $1,916.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,198.72 | 2022-2025 | |
| Medtronic, INC. | $454.96 | 2022-2024 | Signia, Endo Gia Ultra, Appose Ulc |
| Tela Bio, INC. | $118.23 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $106.49 | 2024 | Irrisept |
| Ethicon US, LLC | $105.58 | 2019-2025 | Surgicel Nu-Knit, Dermabond, Stratafix |
| Smith+Nephew, INC. | $101.96 | 2022-2024 | Collagenase Santyl |
| Davol INC. | $57.35 | 2020-2023 | Phasix Mesh |
| Csl Behring | $47.40 | 2024 | Kcentra |
| Stryker Corporation | $46.97 | 2023 | Spy-Phi System |
| Boston Scientific Corporation | $37.46 | 2025 | Overstitch Endoscopic Suturing System |
| Phathom Pharmaceuticals, INC. | $35.82 | 2024 | Voquezna |
| Molli Surgical (US) INC | $31.58 | 2024 | |
| Endo Pharmaceuticals INC. | $26.75 | 2019 | |
| Microline Surgical INC | $23.27 | 2024 | |
| Paratek Pharmaceuticals, INC. | $21.46 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.20 | 2023 | Exparel |
| Ambu INC. | $19.67 | 2022 | |
| Becton, Dickinson and Company | $19.66 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $18.94 | 2023 | Keytruda, Lynparza |
| Abbvie INC. | $18.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.79 | 2023 | Gattex |
| Teleflex LLC | $13.31 | 2023 | Titan Sgs Standard Gastric Stapler |
| Acell, INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Perna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.